BioGaia AB Series B | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK11.94 |
Market Cap |
SEK7.05 B |
Shares Outstanding |
16.6 M |
Public Float |
14.07 M |
Address |
Kungsbroplan 3 Stockholm AB 112 27 Sweden |
Employees | - |
Website | http://www.biogaia.com |
Updated | 07/08/2019 |
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment is comprised of sales of drops, oral rehydration solutions (ORS), digestive health tablets and also cultures as an ingredient in a licensee's products, as well as royalties pertaining to pediatric products. |